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ABSTRAK 
Latarbelakang 
Epilepsi dan  fungsi kognitif mempunyai hubungan yang berkait rapat. Kesan sawan 
boleh menyebabkan gangguan dan kerosakan pada fungsi kognitif pesakit. Faktor-faktor 
yang mendorong kepada gangguan fungsi kognitif dalam epilepsi boleh dikategorikan 
kepada faktor sosiodemografik, faktor berkaitan sawan, faktor psikososial dan faktor 
rawatan. Kajian ini bertujuan menilai fungsi kognitif (intelektual (IQ), memori dan 
bahasa) dan faktor-faktor yang berkaitan dengan kelemahan fungsi kognitif dikalangan 
pesakit epilepsi dalam masyarakat setempat. Kajian ini diharapkan boleh membantu 
meningkatkan kualiti penjagaan pesakit dan rawatan penyakit epilepsi.  
Metodologi 
Ini merupakan kajian hirisan lintang yang mengambil masa setahun bermula dari bulan 
November 2015 hingga November 2016 di Hospital USM. Pesakit epilepsi berumur 16 
sehingga 65 tahun yang menghadiri temujanji rawatan susulan di Klinik Neurologi,yang 
memenuhi syarat kemasukan serta bersetuju akan dipilih  untuk terlibat di dalam kajian 
ini. Saiz sample terbesar yang diperlukan ialah 111 orang. Data demografi, faktor 
berkaitan sawan dan sejarah rawatan direkodkan. Pesakit kemudiannya menjalani satu 
set ujian neuropsikologi yang mana dijalankan oleh pegawai yang telah dilatih dalam 
bidang ujian neuropsikologi. Komponen yang dikaji adalah IQ, memori dan bahasa. 
Wechsler Abbreviated Scale of Intelligence (WASI) digunakan untuk mengkaji kadar 
IQ, manakala tahap memori dikaji menggunakan Wechsler Memory Scale (WMS) dan 
komponen bahasa dikaji menggunakan Verbal Fluency Test. Data-data ini dianalisa 
menggunakan ‘correlation’ dan ‘logistik regression’ untuk mengetahui faktor-faktor 
berkaitan kemerosotan fungsi kognitif dikalangan pesakit Epilepsi. 
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Keputusan 
135 orang subjek dianalisa. Min umur subjek  yang terlibat di dalam kajian ini adalah 30 
± 10.57 tahun. Min semasa diagnosis mula dikesan adalah 14+4.82 tahun. Min tempoh 
penyakit dihidapi adalah 15 ± 7.51 tahun, min bilangan serangan sawan 3 ± 1.41 kali 
sebulan dan min bilangan antiepileptic ialah 2 ± 0.85 ubat. Majoriti pesakit adalah 
berbangsa Melayu (71.9%). 70 orang daripada jumlah subjek adalah perempuan (51.9%) 
dan 65 orang adalah lelaki (48.1%). 58.2% menerima tahap pendidikan tinggi and 
60.7% subjek adalah tidak bekerja atau masih belajar. 72.6% tidak mempunyai sejarah 
status epileptikus yang melebihi 30 minit. Ketiadaan sejarah keluarga epilepsi 
dikalangan 92.6% subjek dan 85.9% subjek tiada ko-morbiditi. Min kadar intelektual 
(FSIQ) adalah 85.18 ± 14.27, min kadar total memori 84.65 ± 12.91 dan min kadar 
kelancaran bahasa adalah 38.43 ± 8.57. Analisa ‘multivariate’ menunjukkan umur 
pesakit, tahap pendidikan, tabiat merokok, tempoh penyakit dihidapi, bilangan ubat 
antiepileptik dan sejarah status epileptikus berkait dengan kelemahan fungsi kognitif 
subjek yang dikaji. 
 
 
 
 
 
 
 
	   xii	  
Kesimpulan 
Faktor-faktor sosiodemografi yang mempengaruhi kemerosotan fungsi kognitif pesakit 
epilepsi secara signifikan adalah faktor umur, tahap pendidikan dan tabiat merokok, 
manakala faktor-faktor berkaitan epilepsi termasuklah umur semasa diagnosis, tempoh 
penyakit yang dialami, kekerapan sawan, bilangan ubat anti-epileptik dan juga sejarah 
‘status epileptikus’ yang melebihi 30 minit. Kami mencadangkan pengenalpastian awal 
profil kognitif pesakit melalui ujian saringan secara rutin dan juga ujian neuropsikologi 
ketika diagnosis epilepsi dibuat agar dapat dijadikan satu penilaian permulaan. Sebarang 
perubahan terhadap penilaian ini pada masa akan datang, sama ada disebabkan oleh 
faktor penyakit atau disebabkan kesan ubat anti-epileptik turut perlu dikenalpasti. 
Rawatan awal untuk mengawal sawan di samping rawatan rehabilitasi kognitif adalah 
penting untuk  meningkatkan kualiti hidup pesakit. 
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ABSTRACT 
Background 
Epilepsy and cognition has an interchangeable relationship. The after-effect of seizure 
may cause disturbances or damages to one’s cognitive function. Multiple factors may 
adversely affect cognition in epilepsy, which can be grouped into sociodemographic, 
seizure-related, psychosocial and treatment factors. The objective of this study is to 
evaluate cognitive function (intelligence (IQ), memory and language) and factors 
associated with poor cognition among epilepsy patients in local setting. The knowledge 
of cognitive profile in epileptic patient will assist in improving quality of care and 
treatment of epilepsy patients. 
  Methodology 
This was a cross-sectional study from November 2015 to November 2016 in Hospital 
USM. Epilepsy patients aged 16 to 65 years old who attended follow up at Neurology 
clinic, willing to participate with informed consent and fulfilled the inclusion criteria 
were selected. The largest sample size required for analysis was 111 subjects. 
Demographic data, seizure-related history and treatment were recorded. Patients 
underwent a set of neuropsychological assessment conducted by a trained personnel. 
The components tested were IQ, verbal memory and language. Wechsler Abbreviated 
Scale of Intelligence (WASI) was used to measure IQ level, while verbal memory was 
assessed using the Wechsler Memory Scale (WMS) and Verbal Fluency Test was used 
for language assessment. Variables obtained were analyzed using multiple logistic 
regression to determine the factors associated with cognitive dysfunction among 
epilepsy patients. 
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Result 
135 subjects were analyzed. The mean age of subject in this study was 30 ± 10.57 years 
old. The mean age of onset of epilepsy was 14 ± 4.82 years old. The mean duration of 
illness was 15 ± 7.51 years with mean attack of 3 ± 1.41 times per month and mean 
numbers of anti epileptic drug (AED) was 2 ± 0.85 drugs. Majority of subjects were 
Malay (71.9%). There were 70 female (51.9%) and 65 male (48.1%). 58.2% received 
higher education level and 60.7% were either not working or still studying. 72.6% had 
not experience status epilepticus (SE) of more than 30 minutes. No family history of 
epilepsy in 92.6% and absent of medical co morbidity in 85.9% of patients. The mean 
value of full scale of intelligence quotient (FSIQ) was 85.18 ± 14.27, total memory of 
84.65 ± 12.91 and verbal fluency of 38.43 ± 8.57. Multivariate analysis revealed certain 
factors such as patient’s age, educational level, smoking status, duration of illness, 
number of AED and history of SE of more than 30 minutes were associated with 
impaired cognitive function among subjects studied.  
Conclusion 
There was significant association between cognitive dysfunction and sociodemographic 
factors such as current age, level of education and smoking status. There was also 
significant association with epilepsy characteristics such as age of onset, duration of 
illness, seizure frequency, history of SE of more than 30 minutes and number of AED 
used. We recommend an early recognition of patient’s cognitive profile via routine 
screening and neuropsychological assessment at the time of diagnosis. This would help 
to provide a baseline cognitive function. Any subsequent change in cognition among 
epilepsy patients either due to progression of the disease or the effect of treatment 
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should also be measured. Early seizure control combined with cognitive rehabilitation 
may help to improve quality of life of the patients. 
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CHAPTER ONE 
INTRODUCTION 
1.1 STUDY BACKGROUND AND RATIONALE 
Cognitive function is defined as higher brain function, that is, the capacity of the 
brain to programme adaptive behaviour, solve problems, memorise information and 
focus attention. Epilepsy is a chronic neurological condition characterised by 
recurrent unprovoked seizures.  
Cognitive dysfunction is one of the major contributors to the burden of epilepsy. 
Previous study (Normah et al, 2012) showed that cognitive and psychosocial 
profiles of non-institutionalized epilepsy patients were comparable to those in the 
normal population. Martin et al. (2002; 2005) reported that, in older adults with 
chronic epilepsy, cognitive deficits were similar as compared to healthy elderly in 
several areas of cognition such as verbal memory, expressive language, simple 
visual construction, conceptualization as well as their overall cognitive status. 
Research has shown that many people with epilepsy have cognitive difficulties as a 
result of their seizures (Aldenkamp,2005). The type of cognitive difficulties 
experienced by the epileptic patients depends on the origin of seizure focus in the 
brain. Epilepsy patient may suffer impairment in the ability to briefly retain and 
process information in immediate (working) memory, impaired language ability, 
and impaired executive function ability (Kilgor & Irwin, 2001). This is also 
supported by Rijckevorsel (2006) who found that the most reported cognitive 
complaints in adults with epilepsy are mental slowness, memory impairment and 
attention deficits. 
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Multiple factors may adversely affect cognition in epilepsy, which can be grouped into 
sociodemographic, seizure-related, psychosocial and treatment factors (Dodrill, 1986; 
Dodrill, 2002; Meador, 2002). In Malaysia, research on the factors affecting cognitive 
or neuropsychological outcome in epilepsy is scarce. Normah et al. (2010) conducted a 
study on the predictors of verbal memory in 98 adults with epilepsy and found that 
significant sociodemographic predictors were age, races, level of education and 
occupation. Among seizure-related factors, the significant predictors of verbal memory 
were age of onset, illness duration, duration of sleep and temporal lobe epilepsy 
(TLE). 
Available antiepileptic drugs (AEDs) have the potential to exert detrimental effects on 
cognitive function and therefore compromise patient wellbeing. On the other hand, 
some agents may serve to enhance cognitive function (Eddy et al, 2011). 
While monotherapy is preferable for most patients with epilepsy, monotherapy is 
particularly desirable as epileptic patients with monotherapy scored better cognitive 
functions, than those with polytherapy (Suzette et al, 2013). 
The aim of the study is to evaluate cognition (intelligence (IQ), memory and language) 
and factors associated with cognitive dysfunction among epilepsy patients in Hospital 
Universiti Sains Malaysia. Based on our literature search, we could not find any 
previous similar study in HUSM. We hope this study will provide additional 
knowledge in management of epilepsy among local patients as the neuropsychological 
assessments are most frequently used to aid diagnosis, evaluate the cognitive side 
effects of antiepileptic medications and monitor the cognitive decline in epilepsy 
patients. 
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1.2 OVERVIEW OF EPILEPSY  
1.2.1  Definition  
An epileptic seizure is a transient occurrence of signs and/or symptoms due to 
abnormal excessive or synchronous neuronal activity in the brain.  
Epilepsy is a disorder of the brain characterized by an enduring predisposition to 
generate epileptic seizures, and by the neurobiologic, cognitive, psychological, and 
social consequences of this condition. The definition of epilepsy requires the 
occurrence of at least one epileptic seizure.  
 
1.2.2  Epidemiology 
According to a 2012 survey done by the Center for Disease Control and 
Prevention (CDC) in USA, about 2.3 million adults were diagnosed with active 
epilepsy while an estimate of 1.7 million adults were having inactive epilepsy 
(diagnosed but no seizures for almost 12 months). The World Health 
Organization (WHO) on the other hand, believes that approximately 50 million 
people worldwide are suffering from epilepsy. They also believe that almost 
80% of these reported cases originate from developing countries including 
Malaysia. Epileptic patients make up 1% of the overall Malaysian population. 
 
1.2.3 Burden and impact of disease on economy and productivity 
Patients with epilepsy have high unemployment rate in Malaysia despite a robust 
economy and minimal social security. Besides those who were unemployed, 
many were in part-time or low-income employment (Keang et al, 2013) Patients 
with epilepsy had significantly higher rates of health-related contacts and 
medication use and a higher socioeconomic cost, lower employment rates, and 
income compared with control subjects. 
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1.2.4 Classification of Epilepsy 
The International League Against Epilepsy (ILAE), through the Commission for 
Classification and Terminology, has developed a working classification of seizures 
and epilepsy.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1: ILAE seizure classification 2016 
 
1.2.5 Types of Epilepsy 
In previous classifications, seizures were dichotomized into partial or 
generalized. This classification was inadequate for certain seizure types, such as 
spasms, which may appear generalized, despite being caused by a focal lesion.  
Generalized seizures are conceptualized as those that originate at some point 
within, and rapidly engage bilaterally distributed networks, which can be 
subcortical or cortical structures. A generalized presentation however can still 
arise from a focal lesion, and does not exclude the possibility of a surgical 
remedy. 
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The term focal has replaced partial to describe seizures that originate in 
networks limited to one hemisphere. Focal seizures may arise from either 
subcortical structures or neocortex. 
In addition, the terms simple partial, complex partial, and secondarily 
generalized have been eliminated, since they were difficult to define 
pragmatically and were often used incorrectly. 
Examples of preferred descriptors include: 
- Without impairment of consciousness or awareness 
- Involving subjective sensory or psychic phenomena 
- With impairment of consciousness or awareness, or dyscognitive 
- Evolving to a bilateral convulsive seizure 
 
The term unknown mode of onset is used for seizure types where it remains 
unclear whether onset is focal, generalized, or perhaps either. A key example is 
epileptic spasms, concerning which there has traditionally been controversy, and 
current knowledge is inadequate to specify mode of onset as either focal or 
generalized. 
 
1.2.6 Diagnosis  
  The diagnosis of epilepsy is made when: 
1.At least two unprovoked (or reflex) seizures occurring >24 h apart 
2.One unprovoked (or reflex) seizure and a probability of further seizures similar     
to the general recurrence risk (at least 60%) after two unprovoked seizures, 
occurring over the next 10 years  
3.Diagnosis of an epilepsy syndrome  
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1.2.7 Management  
 
The clinical diagnosis of Epilepsy can be confirmed by abnormalities on the 
 interictal EEG. Video-EEG monitoring is the standard test for classifying the type 
of seizure or syndrome or to diagnose pseudoseizures (ie, to establish a definitive 
diagnosis of spells with impairment of consciousness). A CT scan is often obtained 
to exclude an obvious structural lesion, but an MRI is indicated if the patient 
continues to have seizures.  
The goal of treatment in patients with epileptic seizures is to achieve a seizure-free 
status without adverse effects and monotherapy is desirable because it decreases 
the likelihood of adverse effects and avoids drug interactions. 
 
1.2.8 Prognosis  
The patient's prognosis for disability and for a recurrence of epileptic seizures 
depends on the type of epileptic seizure and the epileptic syndrome in question. 
Impairment of consciousness during a seizure may unpredictably result in 
morbidity or even mortality. 
 
 
 
 
 
 
	   7	  
1.3 OVERVIEW OF COGNITION 
1.3.1 Definition  
Cognition can be defined as the capacity of the brain to process information 
accurately and to program adaptive behaviors. Cognition involves the ability to 
solve problems, to memorize information, or to focus attention. On a higher level, 
it involves dealing with complex situations creatively by transcending from the 
immediate circumstances to anticipate future acting 
 
1.3.2  Definition of cognitive dysfunction 
Cognitive dysfunction or brain fog is the loss of these intellectual abilities. This 
can affect a person's thoughts, memories, and reasoning capabilities, where it 
may manifest as trouble with recalling words, with the ability to do math 
problems, and with one's focus. Cognitive dysfunction can be seen in a variety 
of diseases or disorders. The issue of cognitive dysfunction in epilepsy is still 
challenging for clinicians. Patients with epilepsy frequently report some 
subjective impairment in cognitive functioning, with prevalence rates ranging 
from 44% for difficulties in learning and psychomotor retardation to 59% for 
sleepiness or tiredness (Meador KJ, 2006). In addition, 63% of patients perceive 
that antiepileptic drugs (AEDs) prevent them from achieving activities or goals 
(Trimbler, 2009).  
  
1.3.2 Epidemiology 
Mojs E et al (2007) reported there are about 30% people with cognitive 
dysfunctions connected to epilepsy. Primary emotional and cognitive 
dysfunctions might be caused by the same factor that cause epilepsy or develop 
due to the damage of the central nervous system in the course of epilepsy or are 
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related to the pharmacological treatment. Secondary emotional deficits are 
connected with negative social actions and negative social attitudes toward ill 
persons with epilepsy, mainly concerns on overprotective attitudes or social 
isolation. The prevalence of emotional disturbances is estimated at 5-50% in 
population of patients with epilepsy. The study shows the necessity of 
conducting psychotherapy and neuropsychological rehabilitation in the course of 
epilepsy as a part of schema of treatment. 
1.3.3 Mechanism of cognitive dysfunction 
Executive deficits including poor intelligence and difficult verbal fluency have 
been associated with damage to the most forward areas of the frontal lobes, as 
well as the cortical and subcortical structures that connect to the frontal lobes. 
The executive system involves the prefrontal cortex, basal ganglia and thalamus. 
The frontal lobes typically account for about 40% of the human brain. Frontal 
lobe functions, or more precisely executive functions, develop through 
adolescence. These facts together could explain that attention and executive 
function deficits are impaired whatever the syndrome, especially in younger 
patients. 
The amygdala and hippocampal complex, two medial temporal lobe structures, 
are linked to two independent memory systems, each with unique characteristic 
functions.  
The mechanism of cognitive impairment in epilepsy is complex. Negative 
effects on cognition may occur in the presence or absence of clinically manifest 
seizures, convulsive or nonconvulsive SE that occur during awakening or during 
sleep, and may occur due to focal or generalized EEG epileptic discharges 
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without epileptic symptomatology. Cognitive deficits associated with epilepsy 
and EEG epileptic discharges may be transient, persistent, or progressive. 
1.3.4 Type of Epilepsy commonly associated with severe cognitive impairment 
 
The frontal lobes support high-level cognition comprising executive skills and 
working memory that is vital for daily life functioning, thus frontal lobe epilepsy 
is associated with performance deficits in intelligence, language, and executive 
functions.  
Memory problems are more marked in focal compared to generalized epilepsies, 
particularly short-term memory. The impairment is related to the laterality with 
a verbal learning deficit in the dominant lobe and a figural learning deficit in the 
non-dominant lobe. Impairment is more pronouced in dominant mesio-temporal 
lobe (MTL) epilepsy, with the severity of the deficit negatively correlated with 
the length of active epilepsy. 
1.3.5 Factors associated with cognitive dysfunction 
A number of factors influence the cognitive impact of epilepsy (Fig. 2). These 
include the aetiology of the disorder, in particular, whether there is underlying 
brain damage (Aldenkamp, 2005), epilepsy-related factors for example the 
nature of the epilepsy syndrome (Hommet 2006), duration of illness (Meador et 
al, 2001), location of the epileptogenic focus (Lezak 2004), age at onset (Anne 
et al, 2000) and seizure-related factors for example seizure type, seizure 
frequency, occurrence of status epilepticus (Alexandra et al, 2001) and 
treatment-related factors (Eddy CM et al, 2011) for example type and number of 
anti-epileptic drug, dosage and drug interactions.  
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Figure 2: Factors influence the cognitive impact of epilepsy 
1.3.6 Investigations of cognitive dysfunction 
These include neuropsychology and neuroimaging assessment. A 
neuropsychological assessment in the routine care of people with epilepsy can 
provide a comprehensive and objective assessment of an individual’s cognitive and 
psychological functioning. At times this role may be diagnostic, given that 
impairments in cognition or behavior can provide clues to the lateralization or 
localization of the seizure network, or the nature of the epilepsy syndrome. At 
other times the role may be prognostic, with assessments used to monitor and 
estimate the effect of ongoing seizures or a particular treatment on the future 
cognitive and behavioral functioning of an individual.  
Neuroimaging studies includes functional MRI and volumetric allow the 
assessment of functional and structural damage related to epileptogenic lesions and 
foci, and are helpful to select surgical treatment, conduct intraoperative 
neuronavigation techniques, predict surgical deficits and evaluate patient recovery. 
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1.3.7 Treatment 
Cognitive deficits in epilepsy are usually managed indirectly by aggressive 
seizure control (including earlier epilepsy surgery), selecting anti-epileptics with 
good cognitive profiles, and treating comorbid conditions such as depression. 
The beneficial effects of anti-epileptics in reducing seizures may offset their 
adverse cognitive effects. Direct therapy for cognitive deficits associated with 
epilepsy, such as vagal nerve stimulation, cholinergic replacement and 
stimulants have little evidence base, and are therefore not recommended in 
clinical practice. Memory rehabilitation strategies could be more helpful as a 
direct treatment for significant cognitive difficulties.  
Where relevant, as a part of neurorehabilitation, psychological treatments such 
as cognitive behavior therapy or anxiety management can also be recommended 
to assist patient and family adjustment to epilepsy, complementing medical 
therapies.  
 
1.3.8 Prognosis 
Dementia resulting from progressive long-term cognitive impairment in 
pharmacoresistant epilepsy is a controversial concept. Helmstaedter & Elger 
(1999) have described it as a phantom. A plethora of evidence from cross-
sectional and longitudinal studies shows that the progress of cognitive decline in 
chronic epilepsy is very slow and that, in adult epilepsies, successful treatment 
can stop or partly reverse it. In elderly people, any cognitive decline associated 
with epilepsy is usually due to early epilepsy-related deficit that then follows the 
course of physiological ageing (Elger, 2004).  
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1.3.9 Implication of cognitive dysfunction in management of epilepsy 
Cognitive dysfunction in epilepsy represents an important factor that 
complicates clinical management and contributes to quality of life and outcome 
measures. A number of variables related to the individual patient, the underlying 
brain disorder and the AED treatment play a role. All of these factors need to be 
considered when discussing the cognitive problems of patients with epilepsy. 
Tailored treatment approaches addressing comorbidities and modifiable factors 
represent important strategies. Cognitive problems in epilepsy have represented 
and will continue to represent an important issue in patients with epilepsy. New 
AEDs and treatment strategies including cognitive rehabilitation and epilepsy 
surgery will have to take these aspects into consideration, possibly being as 
crucially as efficacy.  
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CHAPTER TWO 
OBJECTIVES 
2.1  RESEARCH QUESTIONS 
Is there any association between the characteristic of epilepsy and cognitive 
dysfunction in epilepsy patients treated in HUSM? 
2.2 RESEARCH HYPOTHESIS 
1) The younger the age of onset of epilepsy, the lower their cognitive function 
2) The longer the duration of epilepsy, the lower their cognitive function 
3) The worst the seizure control, the lower their cognitive function 
2.3 GENERAL OBJECTIVES 
To evaluate the characteristic of epilepsy patients in HUSM and their cognitive 
function (intelligence (IQ), memory and language) 
2.4 SPECIFIC OBJECTIVES 
1) To determine the socio- demographic factors (age, sex, race, occupation 
and level of education) and characteristic of illness (age of onset, duration, 
severity) in epilepsy patients. 
2)  To evaluate the cognitive function among epilepsy patients 
3) To determine association between age of onset and cognitive 
dysfunction among epilepsy patients 
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4) To determine association between duration of the epilepsy and cognitive 
dysfunction among epilepsy patients. 
5) To determine association between seizure control and cognitive 
dysfunction. 
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CHAPTER THREE 
METHODOLOGY 
3.1 STUDY DESIGN 
A cross sectional study 
3.2 STUDY DURATION 
The study duration was 1 year (from November 2015 to November 2016)  
Patient’s participation required one to two sessions of neuropsychology test 
3.3 STUDY POPULATION 
Epilepsy patients in Hospital Universiti Sains Malaysia 
3.4 STUDY PARTICIPANTS 
Epilepsy patients in Hospital Universiti Sains Malaysia who fulfilled inclusion & 
exclusion criteria 
Inclusion criteria:  
   - Aged >16 year old to 65 years old  
   - Diagnosis of epilepsy was made by neurologist based on standard criteria 
      Exclusion criteria:  
   - Physical disability (i.e. blind or with hearing impairment) 
- Unable to speak or read in English or Malay languages 
- Presence of psychiatric comorbidities  
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- Underlying mental impairment or retardation  
- Epilepsy syndrome associated with mental retardation 
- Other neurological disorders known to cause mental disability (for example 
dementia, post trauma) 
3.5 STUDY SETTING 
Patients with Epilepsy who attended follow up at Epilepsy Clinic (Klinik Pakar 
Perubatan) in HUSM were identified. Patients who met the inclusions and exclusion 
criteria were invited to participate in the study. The patient’s identification data was 
obtained from the patient. The information of treatment history was reviewed in the 
patient’s folder. The data was collected using data collection form. The patient 
underwent a set of neuropsychological assessment conducted by a trained personnel in 
neuropsychology test. The components of the assessment were IQ, verbal memory and 
language. Wechsler Abbreviated Scale of Intelligence (WASI) was used to measure IQ 
level. Verbal memory was assessed using the Wechsler Memory Scale (WMS) and 
Verbal Fluency Test was used for language assessment 
3.6 SAMPLING METHOD 
- Simple random sampling was performed as a basic sampling technique where each 
epileptic patient was chosen entirely by chance and each member of the population has 
an equal chance of being included in the sample. 
- Randomisation was done using random numbers. 
- Epileptic patients who were followed up at Neurology Clinic, Hospital Universiti 
Sains Malaysia were identified during their clinic attendance. 
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3.7 DATA COLLECTION 
- Ethical approval from local Ethics Committee was obtained prior to study 
- List of epilepsy patients under follow up were screened.  
- Subjects were screen for inclusion and exclusion criteria 
- Informed consent was taken prior to the study. 
- Patients who fulfilled inclusion and exclusion criteria and consented to participate in 
the study were given a date for neuropsychological assessment. 
- Patient required 1 to 2 sessions to complete the full sets of assessment. 
- Neuropsychology assessment was performed by a medical staff who was a 
neuropsychologist assistant and was trained in performing the neuropsychology test by 
the neuropsychologist. 
- It was an interviewer guided test, and was carried out in either Bahasa Malaysia or 
English, according to patient’s preference.  
3.8 STUDY TOOLS 
- A set of worldwide-validated neuropsychological assessment was administered to 
determine the IQ profiles, verbal memory and language.  
- Wechsler Abbreviated Scale of Intelligence (WASI) is registered trademark of The 
Psychological Corporation - is administered to measure IQ level. 
- Wechsler Memory Scale - Third Edition (WMS-III) Logical Memory, Verbal Paired 
Associates, and Visual Reproduction from the WMS-III (Wechsler, 1997) were 
administered to measure verbal and visual memory ability.  
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- Verbal Fluency Test: PAS - Test (Spreen & Benton, 1969, 1977), is a test of verbal 
fluency that consists of three trials. Each trial requires the participant to generate as 
many words as he or she can that begin with a specific letter (i.e., P, A, S) during a 
one- minute time period. This measure localizes to the left frontal lobe and was 
administered as an additional measure of executive functioning 
3.9 VARIABLE DEFINITIONS 
3.9.1 Age of Onset 
Age of subject when he/she started to have his/her first seizure 
3.9.2 Higher educational level 
Secondary schooling and above (form 1 to college or university) 
3.9.3 Lower educational level 
Primary schooling and below (standard 6 and below, or not schooling) 
3.9.4 Smoking 
Smoking habit was divided into smoker and non-smoker. Smoker include patient 
who were still smoking for the past 3 months and non smokers were those who 
never smoke or already stopped for past 3 months 
3.9.5 Drinking alcohol 
Drinking habit was divided into alcoholic and non-alcoholic. The number of 
alcoholic drinks they had consumed in the last 7 days. This information was 
divided into “measures” of spirits, “glasses” of wine, and “pints” of beer. A 
standard measure of spirits and a glass of wine are considered to contain 8 g of 
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alcohol, while a pint of beer contains 16 g of alcohol. Participants were also asked 
to report the frequency of their drinking over the last 12 months by circling one of 
six specified options (twice a day or more, almost daily, once or twice a week, 
once or twice a month, special occasions only, none). 
3.9.6 Status epilepticus (of more than 30 minutes) 
History of single or recurrent convulsion that last for more than 30 minutes and are 
interrupted by only brief episode of partial recovery 
3.9.7 Scoring system of intelligence and verbal fluency  
SCORE INTERPRETATION 
>130 Very superior 
120-129 Superior 
110-119 High average 
90-109 Average 
80-89 Low average 
70-79 Borderline 
55-69 Mild retardation 
40-54 Moderate retardation 
25-39 Severe retardation 
<24 Profound retardation 
Table 3.1 Wechsler score classification of intelligence and memory (Wechsler, 1997) 
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SCORE INTERPRETATION 
>53 Superior 
45-52 High average 
31-44 Average 
26-30 Low average 
24-25 Borderline 
17-23 Defective 
<17 Very defective 
Table 3.2 Verbal fluency test score (Spreen & Benton, 1969, 1977) 
3.9.8 Normal cognitive function 
Individuals with IQ and memory scores of more than 80 and verbal fluency score 
of more than 25 
3.9.9 Cognitive dysfunction 
Individuals with IQ and memory scores of less than 80 and verbal fluency score of 
less than 25 
3.9.10 Seizure control 
No focal or generalized seizure within past 1 year with AED 
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3.10 SAMPLE SIZE CALCULATION 
For objective number 2, sample size is calculated by using single mean formula 
 
With: 
n = sample size 
Z = constant value of 1.96 
σ = Population standard deviation 
E = estimated difference from population mean (standard deviation * effect size) 
Intelligence (IQ) n = [(1.96)(13.43)/2.5] 
    = 111 
Normah et al, Science  
Direct 2010 
Memory n = {(1.96)(12.36)/2.5] 
    = 94 
Kenneth et al , Arch  
Neurol. 1995;52(10) 
Verbal fluency/language *no previous study 
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For Objective no 3, 4, and 5, sample size calculated using correlation coefficient 
formula: 
 
 
    Age of onset of epilepsy r  r value of 0.42 to 0.83 
    making n = 43 
    Hermann et al, Epilepsia.  
     2002 
    Duration of epilepsy r  r value of 0.51 to 0.68 
    making n = 28 
    Richard et al, CrossMark,  
    1980 
    Seizure control * No previous study 
 
Largest sample size calculated from Objective no.2 (111 subjects) 
Hence, 111/(1-drop out rate) = 111/(1-0.2) = 111/0.8 = 138 subjects 
Thus, 138 subjects needed with expected 20% dropout rate to achieve 80% power of 
study 
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3.11 STATISTICAL ANALYSES 
All statistical analyses were performed using the Statistical Program for Social 
Sciences (SPSS version 20). The steps of statistical data analyses were as follow: 
    i) Descriptive Analysis 
            ii) Univariate Analysis 
iii) Multivariate Analysis 
Descriptive Analysis 
For descriptive analysis, numerical variables were described as mean and standard 
deviation. Categorical data were presented in frequency and percentage units. 
Univariate Analysis 
For univariate analysis, simple logistic regression was used to determine the 
potential factors associated with impaired cognitive function among Epilepsy 
patients. Any factors with a p value less than 0.25 would be included in the 
multivariate analysis.  
Multivariate Analysis 
Multivariate analysis was used to look for factors associated with cognitive 
dysfunction among epilepsy patient. Stepwise methods, both forward and 
backward, with both logistic regression tests were used to obtain the preliminary 
model. The variables that remained significant after these methods were 
subsequently checked for interaction and multicollinearity. Clinical plausible 
interaction terms were created and entered into the model and an interaction was 
considered significant if the P value was < 0.05. To check the models’s goodness 
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of fit, Hosmer-Lemeshow test and classification table Receiver Operating 
Characteristic (ROC) curves were computed. 
 
3.12 FLOWCHART OF THE STUDY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Epilepsy patients attended Neurology Clinic, Klinik Pakar 
Perubatan HUSM from March 2016-September 2016 
150 patients 
12 patients excluded: 
-4 with mental challenged 
-5  not consented 
-3 post trauma 
138 patients fulfilled study 
criteria 
3 patients excluded 
- not completed the full 
set of  assessment 
135 patients available for 
analysis 
Result and conclusion 
